Actionable insights straight to your inbox

Equities logo

Clover Biopharmaceuticals Launches COVID-19 Vaccine Trial in Australia

The company is now the sixth Chinese developer of a potential COVID-19 vaccine to move into human trials.
Everybody knows that biotech ideas can become huge gainers for investors, but understanding the technology platforms, the unmet needs and the valuations can be daunting, especially in spaces where
Shares of Dynavax Technologies (DVAX) are off nearly 4 percent on Thursday after a huge spike in volume just before noon. Major Trade Moves Many DVAX Shares in Short Timeframe There’s no
Clinical-stage biopharmaceutical company Dynavax Technologies Corporation (DVAX) jumped almost 6.5 percent in early trading on Friday after the company announced the pricing for its planned
Wall Street saw stocks higher by Friday’s closing bell, with all indices gaining modestly and the Standard & Poor’s 500 closing out the week on yet another record-high, and the